Stay updated with breaking news from 03664210. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com began coverage on shares of Antares Pharma (NASDAQ:ATRS – Get Rating) in a note issued to investors on Saturday. The brokerage set a “sell” rating on the specialty pharmaceutical company’s stock. ATRS has been the subject of a number of other research reports. HC Wainwright lowered Antares Pharma from a “buy” rating to a […]
Antares Pharma (NASDAQ:ATRS – Get Rating) and IRadimed (NASDAQ:IRMD – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, profitability, earnings, analyst recommendations, institutional ownership and dividends. Valuation & Earnings This table compares Antares Pharma and IRadimed’s […]
Antares Pharma (NASDAQ:ATRS – Get Rating) and Dynatronics (NASDAQ:DYNT – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, valuation, profitability, institutional ownership, dividends and analyst recommendations. Profitability This table compares Antares Pharma and Dynatronics’ net margins, […]
Shares of Antares Pharma, Inc. (NASDAQ:ATRS – Get Rating) have earned an average recommendation of “Hold” from the seven research firms that are covering the firm, MarketBeat Ratings reports. Six investment analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company. The average 1-year target price […]
Antares Pharma (NASDAQ:ATRS – Get Rating) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a note issued to investors on Tuesday. Other equities analysts have also recently issued research reports about the stock. Zacks Investment Research raised shares of Antares Pharma from a “sell” rating to a “hold” rating in […]